JW Pharmaceutical Corporation (001065.KS)
KRW 29450.0
(-1.01%)
KRW 29450.0
(-1.01%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 87.15 Billion | 56.76 Billion | 18.12 Billion | 63.05 Billion | 55.53 Billion | 52.1 Billion |
| Net Income | 35.09 Billion | 29.85 Billion | -1.44 Billion | -15.27 Billion | -25.27 Billion | 8.05 Billion |
| Depreciation & Amortization | 22.44 Billion | 16.83 Billion | 16.11 Billion | 20.68 Billion | 20.34 Billion | 17.68 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -20.26 Billion | -6.16 Billion | -46.05 Billion | 35.21 Billion | 62.91 Billion | -393.62 Million |
| Other non-cash items | 49.87 Billion | 16.24 Billion | 49.5 Billion | 22.42 Billion | -2.45 Billion | 26.76 Billion |
| Investing Cash Flow | -63.83 Billion | -18.91 Billion | -22.86 Billion | -79.42 Billion | -21.98 Billion | -13.91 Billion |
| Investments in PPE | -42.96 Billion | -12.35 Billion | -12.9 Billion | -15.03 Billion | -13.09 Billion | -8.34 Billion |
| Acquisitions | -12.03 Billion | -40.88 Million | 384.96 Million | -5.62 Billion | -5.34 Billion | -5.17 Billion |
| Investment purchases | -61.34 Billion | -73.81 Billion | -140.02 Billion | -56.34 Billion | -15.47 Billion | 644.4 Million |
| Sales/Maturities of investments | 69.6 Billion | 47.47 Billion | 141.1 Billion | 16.64 Million | 12 Billion | 140 Million |
| Other Investing Activities | -17.09 Billion | 19.81 Billion | -11.43 Billion | -2.43 Billion | -67.19 Million | -1.17 Billion |
| Financing Cash Flow | -41.19 Billion | -36.9 Billion | 27.2 Billion | -14 Billion | -24.16 Billion | -41.18 Billion |
| Debt repayment | -28.18 Billion | -177 Billion | -98.65 Billion | -169.3 Billion | -158.87 Billion | -200.13 Billion |
| Dividends payments | -8.81 Billion | -7.35 Billion | -7.14 Billion | -6.95 Billion | -6.81 Billion | -5.82 Billion |
| Common Stock Repurchased | -260.87 Million | -281.6 Million | -412.29 Million | -224.24 Million | -258.45 Million | -9.37 Billion |
| Common Stock Issuance | -3.87 Billion | 9.99 Billion | 398.47 Million | - | 166.76 Billion | 184.82 Billion |
| Other Financing Activities | -54 Million | 137.73 Billion | 133.02 Billion | 162.47 Billion | -24.97 Billion | -10 Billion |
| Accounts receivables | -3.16 Billion | -4.35 Billion | -41.29 Billion | 45.69 Billion | 38.27 Billion | 28.91 Billion |
| Accounts payables | -9.53 Billion | 31.65 Billion | 3.72 Billion | 2.83 Billion | -632.93 Million | -15.16 Billion |
| Inventory | 8.91 Billion | -11.54 Billion | -2.65 Billion | -8.87 Billion | 19.78 Billion | -5.78 Billion |
| Other working capital | -16.48 Billion | -21.92 Billion | -5.83 Billion | -4.43 Billion | 5.48 Billion | 5.39 Billion |
| Cash at beginning of period | 33.89 Billion | 33.36 Billion | 10.45 Billion | 41.86 Billion | 30.94 Billion | 32.09 Billion |
| Cash at end of period | 15.9 Billion | 33.89 Billion | 33.36 Billion | 10.45 Billion | 41.86 Billion | 30.94 Billion |
| Capital Expenditure | -42.96 Billion | -12.35 Billion | -12.9 Billion | -15.03 Billion | -13.09 Billion | -8.34 Billion |
| Effect of forex changes on cash | -120.69 Million | -406.37 Million | 458.71 Million | -1.03 Billion | 1.52 Billion | 1.84 Billion |
| Net cash flow / Change in cash | -17.98 Billion | 531.44 Million | 22.91 Billion | -31.41 Billion | 10.91 Billion | -1.14 Billion |
| Free Cash Flow | 44.19 Billion | 44.41 Billion | 5.22 Billion | 48.01 Billion | 42.43 Billion | 43.76 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 8.07 Billion | 19.05 Billion | 35.09 Billion | 23.68 Billion | -17.91 Billion | 15.97 Billion |
| Depreciation & Amortization | 4.73 Billion | 4.86 Billion | 22.44 Billion | 5.05 Billion | 4.71 Billion | 6.15 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 7.77 Billion | 3.5 Billion | -20.26 Billion | -5.25 Billion | 13.66 Billion | -7.53 Billion |
| Other non-cash items | 3.65 Billion | 8.51 Billion | 49.87 Billion | 11.15 Billion | 35.48 Billion | 1.72 Billion |
| Investing Cash Flow | -1.94 Billion | 1.31 Billion | -63.83 Billion | -9.62 Billion | -5.24 Billion | -7.71 Billion |
| Investments in PPE | -6.02 Billion | -4.76 Billion | -42.96 Billion | -8.08 Billion | -7.53 Billion | -8.43 Billion |
| Acquisitions | 27.11 Million | 3.4 Million | -12.03 Billion | 144.72 Thousand | -194.53 Million | -2.29 Billion |
| Investment purchases | - | - | -61.34 Billion | -3.44 Billion | -25.26 Billion | -32.02 Billion |
| Sales/Maturities of investments | 1 Billion | 2.07 Billion | 69.6 Billion | 2.66 Billion | 24.99 Billion | 37.24 Billion |
| Other Investing Activities | 3.05 Billion | 4 Billion | -17.09 Billion | -769.17 Million | 2.74 Billion | -2.2 Billion |
| Financing Cash Flow | -11.67 Billion | -20.5 Billion | -41.19 Billion | -41.97 Billion | -13.18 Billion | -16.25 Billion |
| Debt repayment | -841.84 Million | -18.96 Billion | -28.18 Billion | -40.78 Billion | -72.68 Billion | -80.49 Billion |
| Dividends payments | -9.66 Billion | - | -8.81 Billion | -10.00 | - | -8.81 Billion |
| Common Stock Repurchased | - | -332.44 Million | -260.87 Million | 400.00 | - | -260.87 Million |
| Common Stock Issuance | - | - | -3.87 Billion | -1.19 Billion | - | 9.07 Billion |
| Other Financing Activities | -1.16 Billion | 10.00 | -54 Million | -390.00 | 59.49 Billion | 64.24 Billion |
| Accounts receivables | -3.99 Billion | 9.83 Billion | -3.16 Billion | 2.12 Billion | -7.01 Billion | -8.19 Billion |
| Accounts payables | 3.48 Billion | 7.4 Billion | -9.53 Billion | 1.41 Billion | 14.19 Billion | -915.57 Million |
| Inventory | -222.13 Million | -7.87 Billion | 8.91 Billion | 6.86 Billion | 6.22 Billion | -204.87 Million |
| Other working capital | 8.51 Billion | -5.85 Billion | -16.48 Billion | -15.67 Billion | 267.46 Million | 1.78 Billion |
| Cash at beginning of period | 32.68 Billion | 15.9 Billion | 33.89 Billion | 33.12 Billion | 15.91 Billion | 23.56 Billion |
| Cash at end of period | 33.28 Billion | 32.68 Billion | 15.9 Billion | 15.9 Billion | 33.12 Billion | 15.91 Billion |
| Capital Expenditure | -6.02 Billion | -4.76 Billion | -42.96 Billion | -8.08 Billion | -7.53 Billion | -8.43 Billion |
| Effect of forex changes on cash | - | 388.34 Million | -120.69 Million | -241.9 Million | -318.53 Million | 142.09 Thousand |
| Net cash flow / Change in cash | 598.33 Million | 16.77 Billion | -17.98 Billion | -17.21 Billion | 17.2 Billion | -7.65 Billion |
| Free Cash Flow | 8 Billion | 30.8 Billion | 44.19 Billion | 26.55 Billion | 28.41 Billion | 7.87 Billion |
BG
300671
ARV
002614
IMJS
SNX